Canada markets closed

Timber Pharmaceuticals, Inc. (TMBR)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
1.0800-0.0900 (-7.69%)
At close: 4:00PM EDT

Timber Pharmaceuticals, Inc.

110 Allen Road
Suite 401
Basking Ridge, NJ 07920
United States
914 205 3481
http://www.timberpharma.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees6

Key Executives

NameTitlePayExercisedYear Born
Mr. John Koconis M.B.A.Chairman, CEO & Pres507.26kN/A1970
Mr. Joseph LuccheseExec. VP & CFO360.2kN/A1968
Mr. Zachary RomeCOO, Exec. VP, Sec. & Director300.67kN/A1984
Dr. Alan Mendelsohn M.D.Chief Medical OfficerN/AN/A1963
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical dermatology company, focused on the development and commercialization of treatments for orphan dermatologic diseases. The company was founded in 2019 and is headquartered in Basking Ridge, New Jersey.

Corporate Governance

Timber Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.